For example, PD-L1–targeted DOX-loaded immunoliposomes in melanoma-bearing mice, induced full tumor regression in 20% of the animals, enhanced activated cytotoxic T-lymphocyte infiltration, and significantly improved survival compared to non-targeted liposomes and free DOX [87]. This evidence concerns the gene CD274 and melanoma.